Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 12.70M | $ 200.00K | $ 6.60M | $ 39.00M | $ 25.70M |
Total Assets | $ 1.24B | $ 1.14B | $ 1.06B | $ 1.04B | $ 1.01B |
Total Debt | $ 75.40M | $ 106.20M | $ 93.60M | $ 131.40M | $ 146.70M |
Net Debt | $ 62.70M | $ 106.00M | $ 87.00M | $ 92.40M | $ 121.00M |
Total Liabilities | $ 446.50M | $ 374.20M | $ 342.60M | $ 355.80M | $ 376.00M |
Stockholders Equity | $ 792.50M | $ 768.90M | $ 717.60M | $ 686.10M | $ 638.10M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |